Vladimir Zaitsev

Rusnano Projects is a private equity and venture capital operating division of the State-owned Rusnano OJSC. The firm was founded in 2007 and is headquartered in Moscow, Russia.

NovaMedica LLC operates as a pharmaceutical company. Its portfolio includes gastroenterology, ophthalmology, and neurology. The company was founded in 2012 and is headquartered in Moscow, Russian Federation.

RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia.

OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA.

OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel.

Nanoderm-Profi OOO develops and manufactures anti-aging cosmetics. The firm develops and implements nanotechnologies in the field of dermatology and cosmetology and produces cosmetics under the brand NanoDerm. The company was founded in 2011 and is headquartered in Moscow, Russia.

RusnanoMedInvest LLC provides investment services.

Rusnano Management Co. LLC (Rusnano Management) is a private equity and venture capital subsidiary of the State-owned Rusnano OJSC. The firm was founded in 2013 and is headquartered in Moscow, Russia.

Nanolek Holding Ltd. operates as a holding Cypriot company that provides biotechnological services.

SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation.

PET-Technology OOO operates as a network of nuclear medicine centers. It provides positron emission and computerized tomography, as well as cyberknife treatment services. The company was founded on September 1, 2011 and is headquartered in Moscow, Russia.

Mitotech LLC develops medical nanotechnology solutions. The firm's pipeline has a number of drug candidates based on mitochondria-addressed antioxidant. Its specialties include nanobiotechnology, drug development, research and development in biology and medicine. The company was founded by Maxim Skulachev and John W. Elling in 2009 and is headquartered in Moscow, Russia.

NTpharma LLC develops nanotechnology-based flu vaccines and immune activators. It employs non-replicating genetically modified viruses carrying genes for target proteins to activate the immune system. The company was founded in 2010 and is headquartered in Moscow, Russia.

NanoBrachyTech CJSC engages in development of nanotechnologies for treatment of cancer. It implements a project on production of micro sources and nanostructures for brachytherapy, based on silicon and phosphorus alloys, for treatment of primary and metastatic liver and pancreatic cancer. The company was founded on June 30, 2009 and is headquartered in Dubna, Russia.

Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation.

Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom.